BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27335186)

  • 1. [Reduction in requirements of oral calcium and 1-25 dihydroxy vitamin D in patients with post-surgical hypoparathyroidism treated with teriparatide (PTH1-34)].
    Gutiérrez-Cerecedo LE; Vergara-López A; Rosas-Barrientos JV; Guillén-González MÁ
    Gac Med Mex; 2016; 152(3):322-8. PubMed ID: 27335186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
    Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
    Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
    Winer KK; Yanovski JA; Cutler GB
    JAMA; 1996 Aug; 276(8):631-6. PubMed ID: 8773636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism.
    Gafni RI; Guthrie LC; Kelly MH; Brillante BA; Christie CM; Reynolds JC; Yovetich NA; James R; Collins MT
    J Bone Miner Res; 2015 Nov; 30(11):2112-8. PubMed ID: 25990370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series.
    Bislev LS; Sikjaer T; Rejnmark L
    Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hypoparathyroidism by active vitamin D].
    Kaji H
    Clin Calcium; 2007 Aug; 17(8):1249-54. PubMed ID: 17660623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-μg or 50-μg Daily Doses.
    Bilezikian JP; Clarke BL; Mannstadt M; Rothman J; Vokes T; Lee HM; Krasner A
    Clin Ther; 2017 Oct; 39(10):2096-2102. PubMed ID: 28942334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review.
    Angelopoulos NG; Goula A; Tolis G
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):50-4. PubMed ID: 17286236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
    Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
    Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism.
    Matarazzo P; Tuli G; Fiore L; Mussa A; Feyles F; Peiretti V; Lala R
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):53-9. PubMed ID: 23945122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.
    Winer KK; Ko CW; Reynolds JC; Dowdy K; Keil M; Peterson D; Gerber LH; McGarvey C; Cutler GB
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4214-20. PubMed ID: 12970289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of unresponsive hypoparathyroidism when the oral route administration is not possible: considering subcutaneous teriparatide.
    Añón AO; Porta MM; López CQ; Hanzu FA; Rabinovich IH
    Endocrinol Nutr; 2015; 62(7):361-2. PubMed ID: 25959089
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of long term treatment of unresponsive hypoparathyroidism using multipulse subcutaneous infusion of teriparatide.
    Díaz-Soto G; Mora-Porta M; Nicolau J; Perea V; Halperin I; Puig-Domingo M
    Horm Metab Res; 2012 Sep; 44(9):708-10. PubMed ID: 22473758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.
    Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.
    Winer KK; Yanovski JA; Sarani B; Cutler GB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3480-6. PubMed ID: 9768650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
    Mannstadt M; Clarke BL; Bilezikian JP; Bone H; Denham D; Levine MA; Peacock M; Rothman J; Shoback DM; Warren ML; Watts NB; Lee HM; Sherry N; Vokes TJ
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5136-5147. PubMed ID: 31369089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hypoparathyroidism and treatment with teriparatide.
    Marcucci G; Masi L; Cianferotti L; Giusti F; Fossi C; Parri S; Gronchi G; Brandi ML
    Endocrine; 2021 Apr; 72(1):249-259. PubMed ID: 33538953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
    Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.